ARS Pharmaceuticals (SPRY) Prepaid Assets (2020 - 2026)

ARS Pharmaceuticals (SPRY) has 7 years of Prepaid Assets data on file, last reported at $6.8 million in Q1 2026.

• For the quarter ending Q1 2026, Prepaid Assets fell 41.28% year-over-year to $6.8 million; the trailing twelve-month figure through Mar 2026 stood at $6.8 million (down 41.28% YoY), and the FY2025 full-year result was $6.2 million, down 10.05% from the prior year.
• Prepaid Assets rose to $6.8 million in Q1 2026, from $6.2 million in the prior quarter.
• In the past five years, Prepaid Assets ranged from a high of $11.6 million in Q1 2025 to a low of $137000.0 in Q3 2024.
• A 5-year average of $3.8 million and a median of $3.3 million in 2022 frame the typical range for Prepaid Assets.
• Across the five-year window, Prepaid Assets tumbled 86.75% in 2024 and surged 4586.86% in 2025, its largest moves.
• Tracing SPRY's Prepaid Assets over 5 years: stood at $3.3 million in 2022, then plunged by 66.13% to $1.1 million in 2023, then surged by 512.63% to $6.9 million in 2024, then declined by 10.05% to $6.2 million in 2025, then advanced by 9.59% to $6.8 million in 2026.
• Business Quant data shows SPRY's Prepaid Assets at $6.8 million in Q1 2026, $6.2 million in Q4 2025, and $6.4 million in Q3 2025.